Long-Term Outcomes of Adjuvant Denosumab in Breast Cancer-Reference-Cited by-同舟云学术

Long-Term Outcomes of Adjuvant Denosumab in Breast Cancer

Published:2022-11-22 Issue:12 Volume:1 Page:
ISSN:2766-5526
Container-title:NEJM Evidence
language:en
Short-container-title:NEJM Evidence

Author:

Gnant Michael¹²,Frantal Sophie²,Pfeiler Georg³,Steger Guenther G.⁴,Egle Daniel⁵,Greil Richard⁶,Fitzal Florian⁷,Wette Viktor⁸,Balic Marija⁹,Haslbauer Ferdinand¹⁰,Melbinger-Zeinitzer Elisabeth¹¹,Bjelic-Radisic Vesna¹²¹³,Artner-Matuschek Silvia¹⁴,Kainberger Franz¹⁵,Ritter Magdalena⁵,Rinnerthaler Gabriel⁶,Sevelda Paul¹⁶,Bergh Jonas¹⁷,Kacerovsky-Strobl Stephanie⁷¹⁸,Suppan Christoph⁹,Brunner Christine⁵,Deutschmann Christine³,Gampenrieder Simon P.⁶,Fohler Hannes²,Jakesz Raimund⁷,Fesl Christian²,Singer Christian³

Affiliation:

1. Medical University of Vienna, Comprehensive Cancer Center, Vienna

2. ABCSG (Austrian Breast & Colorectal Cancer Study Group), Vienna

3. Department of Gynecology and Gynecological Oncology, Comprehensive Cancer Center, Medical University of Vienna, Vienna

4. Department of Internal Medicine I, Medical University of Vienna, Vienna

5. Department of Obstetrics and Gynecology, Medical University of Innsbruck, Innsbruck, Austria

6. Department of Internal Medicine III, Paracelsus Medical University Salzburg, Salzburg Cancer Research Institute, Center for Clinical Cancer and Immunology Trials; Cancer Cluster Salzburg, Salzburg, Austria

7. Department of General Surgery and Breast Health Center of the Comprehensive Cancer Center, Medical University of Vienna, Vienna

8. Breast Center Carinthia, St. Veit, Austria

9. Division of Oncology, Department of Internal Medicine, and Comprehensive Cancer Center, Medical University of Graz, Graz, Austria

10. Department of Internal Medicine, Salzkammergut Klinikum Hospital Vöcklabruck, Vöcklabruck, Austria

11. Department of Surgery, Hospital Wolfsberg, Wolfsberg, Austria

12. Department of Gynecology and Obstetrics, Medical University of Graz, Graz, Austria

13. Breast Unit, Helios University Hospital Wuppertal, Wuppertal Germany, University Witten/Herdecke, Germany

14. Department of Gynecology, Hanusch Hospital Vienna, Vienna

15. Division of Neuro- and Musculoskeletal Radiology, Department of Biomedical Imaging and Image-Guided Therapy, Medical University of Vienna, Vienna

16. Department of Gynecology, Karl Landsteiner Institute for Gynecologic Oncology and Senology, Hospital Hietzing, Vienna

17. Department of Oncology-Pathology, Cancer Research Karolinska Institutet, Stockholm

18. Breast Health Center, St. Francis Hospital Vienna, Vienna

Publisher

Massachusetts Medical Society

Reference30 articles.

1. Epidemiological trends of women’s cancers from 1990 to 2019 at the global, regional, and national levels: a population-based study

2. Breast cancer

3. Duration of Adjuvant Aromatase-Inhibitor Therapy in Postmenopausal Breast Cancer

4. Customizing local and systemic therapies for women with early breast cancer: the St. Gallen International Consensus Guidelines for treatment of early breast cancer 2021

5. Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The use of denosumab in osteoporosis – an update on efficacy and drug safety;Expert Opinion on Drug Safety;2024-09-11

2. Os tumoral;Revue du Rhumatisme;2024-08

3. MASCC/ISOO Clinical Practice Statement: Adjuvant bone-modifying agents in primary breast cancer patients - prevention of medication-related osteonecrosis of the jaw;Supportive Care in Cancer;2024-07-25

4. Breast Cancer, Version 3.2024, NCCN Clinical Practice Guidelines in Oncology;Journal of the National Comprehensive Cancer Network;2024-07

5. Cancer risk in patients treated with denosumab compared with alendronate: A population-based cohort study;Bone;2024-05